Egypt vs Malta: Access to anti-retroviral drugs, female
Egypt
46.0%
in 2024
Malta
47.0%
in 2024
Egypt rank
125th
Malta rank
124th
Access to anti-retroviral drugs, female over time
- Egypt
- Malta
How they compare
Malta currently reports 47.0% against 46.0% in Egypt, a difference of 1.0%.
Across all 25 years both countries report, Malta has been ahead every year.
Egypt ranks 125th and Malta ranks 124th of 141 countries.
Malta has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Egypt | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.1% | 24.5% | 24.4% | Malta |
| 2010s | 14.0% | 49.1% | 35.1% | Malta |
| 2020s | 36.8% | 68.4% | 31.6% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Egypt or Malta?
- Malta, at 47.0% against 46.0% in Egypt as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Egypt and Malta?
- 1.0%, with Malta ahead.
- How many years of comparable data are there for Egypt and Malta?
- 25 years are reported by both, from 2000 to 2024.
- How do Egypt and Malta rank globally for access to anti-retroviral drugs, female?
- Egypt ranks 125th and Malta ranks 124th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.